Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Free Cash Flow (2020 - 2023)

Terns Pharmaceuticals' Free Cash Flow history spans 4 years, with the latest figure at -$19.4 million for Q4 2023.

  • For Q4 2023, Free Cash Flow fell 72.17% year-over-year to -$19.4 million; the TTM value through Dec 2023 reached -$67.4 million, down 36.57%, while the annual FY2025 figure was -$82.2 million, 17.3% down from the prior year.
  • Free Cash Flow reached -$19.4 million in Q4 2023 per TERN's latest filing, up from -$20.7 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$6.3 million in Q3 2020 to a low of -$20.7 million in Q3 2023.
  • Average Free Cash Flow over 4 years is -$11.8 million, with a median of -$11.2 million recorded in 2022.
  • Peak YoY movement for Free Cash Flow: plummeted 85.82% in 2021, then increased 5.56% in 2022.
  • A 4-year view of Free Cash Flow shows it stood at -$7.4 million in 2020, then crashed by 46.21% to -$10.9 million in 2021, then fell by 3.46% to -$11.2 million in 2022, then tumbled by 72.17% to -$19.4 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Free Cash Flow are -$19.4 million (Q4 2023), -$20.7 million (Q3 2023), and -$13.0 million (Q2 2023).